Естественные роды и нежная материнская забота. Мудрость и наука о выборе естественных путей беременности, родов и воспитания. Михаил Титов
Читать онлайн книгу.
id="note90">
90
U.S. Preventive Services Task Force. Screening Congenital Disorders: Screening for Down Syndrome. Guide to Clinical Preventive Services. 2nd edn. Rockville MD: Agency for Healthcare Research and Quality, 1996.
91
Centre for Disease Control. Economic Costs of Birth Defects and Cerebral Palsy – United States, 1992. Morbidity and Mortality Weekly Report 1995; 44 (37):694—9.
92
Cusick W, et al. Combined fi rst-trimester versus second-trimester serum screening for Down syndrome: a cost analysis. Am J Obstet Gynecol 2003; 188 (3):745—51.
93
Alfi revic Z, Neilson JP. Antenatal screening for Down’s syndrome. Br Med J 2004; 329 (7470):811—2, p 812.
94
Newnham JP, et al. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomized controlled trial. Lancet 2004; 364 (9450):2038—44, p 2043.
95
Antsaklis AJ, et al. False positive serum biochemical screening and subsequent fetal loss in women less than 35 years of age. Br J Obstet Gynaecol 2001; 108 (6):589—93.
96
Papantoniou NE, et al. Risk factors predisposing to fetal loss following a second trimester amniocentesis. Br J Obstet Gynaecol 2001; 108 (10):1053—6.
97
Squier M, et al. Five cases of brain injury following amniocentesis in mid-term pregnancy. Dev Med Child Neurol 2000; 42 (8):554—60.
98
Squier M, et al. Five cases of brain injury following amniocentesis in mid-term pregnancy. Dev Med Child Neurol 2000; 42 (8):554—60.
99
Thompson PJ, et al. Lung function following fi rst-trimester amniocentesis or chorion villus sampling. Fetal Diagn Ther 1991; 6 (3—4):148—52.
100
Milner AD, et al. The effects of mid-trimester amniocentesis on lung function in the neonatal period. Eur J Pediatr 1992; 151 (6):458—60.
101
Greenough A, et al. Invasive antenatal procedures and requirement for neonatal intensive care unit admission. Eur J Pediatr 1997; 156 (7): 550—2.
102
Medda E, et al. Genetic amniocentesis: a risk factor for preterm delivery? Eur J Obstet Gynecol Reprod Biol 2003; 110 (2):153—8.
103
Enkin M, et al. Effective Care in Pregnancy and Childbirth. 3rd edn. Oxford: Oxford University Press, 2000.
104
Elchalal U, et al. Maternal mortality following diagnostic 2nd-trimester amniocentesis. Fetal Diagn Ther 2004; 19 (2):195—8.
105
Halliday JL, et al. Importance of complete follow-up of spontaneous fetal loss after amniocentesis and chorion villus sampling. Lancet 1992; 340 (8824):886—90.
106
Harris RA, et al. Cost utility of prenatal diagnosis and the risk-based threshold. Lancet 2004; 363 (9405):276—82.
107
Leporrier N, et al. Fetuses with Down’s Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down’s Syndrome not detected by prenatal screening. Br J Obstet Gynaecol 2003; 110 (1):18—21.
108
Stoler JM, et al. Malformations reported in chorionic villus sampling exposed children: a review and analytic synthesis of the literature. Genet Med 1999; 1 (7):315—22.
109
Silver RK, et al. Late fi rst-trimester placental disruption and subsequent gestational hypertension/preeclampsia. Obstet Gynecol 2005; 105 (3):587—92.
110
Statham H, Green J. Serum screening for Down’s syndrome: some women’s experiences. Br Med J 1993; 307 (6897):174—6, p 175.
111
Elkins TE, Brown D. Ethical concerns and future directions in maternal screening for Down syndrome. Womens Health Issues 1995; 5 (1):15—20, p 17.
112
Elkins TE, Brown D. Ethical concerns and future directions in maternal screening for Down syndrome. Womens Health Issues 1995; 5 (1):15—20.
113
Asch A. Prenatal diagnosis and selective abortion: a challenge to practice and policy. Am J Public Health 1999; 89 (11):1649—57.
114
Alderson P. Down’s syndrome: cost, quality and value of life. Soc Sci Med 2001; 53 (5):627—38.
115
Kingsley J, Levitz M. Count us in: Growing up with Down syndrome. San Diego: Harcourt Brace & Company, 1994.
116
Slater C. In Praise of Down Syndrome. Based on an article that appeared in Westminster Mencap’s Newsletter Feedback.
117
Reynolds TM. Down’s syndrome screening is unethical: views of today’s research ethics committees. J Clin Pathol 2003; 56 (4):268—70.
118
Rothman B. The Tentative Pregnancy. Amniocentesis and the sexual politics of motherhood. 2nd edn. London: Pandora, 1994.
119
Sagi M, et al. Prenatal diagnosis of sex chromosome aneuploidy: possible reasons for high rates of pregnancy termination. Prenat Diagn 2001; 21 (6):461—5.